Cargando…
A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial”
OBJECTIVES: Primary Objective: The primary objective is to reduce initiation of mechanical ventilator dependency in patients with moderate to severe CoViD- 19. This will be measured as the difference between the control group and active group for subjects admitted to the hospital for CoViD-19. Secon...
Autores principales: | Tornero, Carlos, Vallejo, Ricardo, Cedeño, David, Orduña, Jorge, Pastor, Ernesto, Belaouchi, Moncef, Escamilla, Benigno, Laredo, Marisa, del Mar Garzando, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316576/ https://www.ncbi.nlm.nih.gov/pubmed/32586395 http://dx.doi.org/10.1186/s13063-020-04486-w |
Ejemplares similares
-
Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I)
por: Tornero, Carlos, et al.
Publicado: (2022) -
Feasibility of Non-Invasive Vagus Nerve Stimulation (gammaCore VET™) for the Treatment of Refractory Seizure Activity in Dogs
por: Robinson, Kelsey, et al.
Publicado: (2020) -
gammaCore for Cluster Headaches: A NICE Medical Technologies Guidance
por: O’Connell, Susan, et al.
Publicado: (2021) -
EHMTI-0363. Quality of life in subjects treated by non-invasive vagus nerve stimulation using gammacore® for the prevention and acute treatment of chronic cluster headache
por: Gaul, C, et al.
Publicado: (2014) -
EHMTI-0362. Non-invasive vagus nerve stimulation with gammacore® for prevention and acute treatment of chronic cluster headache: report from the extension phase of the preva study
por: Gaul, C, et al.
Publicado: (2014)